HERGスクリーニング市場規模、シェア、成長分析：タイプ別、イオンチャネル別、用途別、地域別 - 産業予測 2025～2032年

HERGスクリーニングの世界市場規模は2023年に16億米ドルと評価され、2024年の17億9,000万米ドルから2032年には43億7,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは11.8%で成長する見通しです。

世界のHERGスクリーニング市場は、医薬品の安全性が重視されるようになり、より効率的なスクリーニング手法への需要が高まっていることを背景に、近年一貫した成長を遂げています。製薬およびバイオテクノロジー部門がこの市場をリードしており、薬剤誘発性不整脈のリスクを軽減する信頼性の高い技術を絶えず求めています。薬剤の心毒性に対する意識の高まりは、薬剤開発におけるHERGスクリーニングの重要な役割を強調しています。自動パッチクランプシステムやハイスループットスクリーニングなどの技術の進歩が市場拡大に拍車をかけています。医薬品の安全性に対する規制上の要求が厳しくなっているため、製薬会社はHERGスクリーニングソリューションへの投資を余儀なくされているが、初期費用が高いことが中小企業にとっては課題となっています。さらに、薬剤の心臓安全性プロファイルを正確に予測することは依然として複雑であり、予測モデルを強化するための継続的な調査が必要です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ分析

HERGスクリーニング市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 遺伝子KCNH2
• 変異KCNH2

HERGスクリーニング市場規模：イオンチャンネル別& CAGR（2025-2032）

• 市場概要
• 電圧ゲート
• リガンドゲート

HERGスクリーニング市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 抗不整脈薬
• 抗炎症薬
• 抗生物質
• その他

HERGスクリーニング市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Cytocentrics AG（Germany）
• Charles River Laboratories（US）
• Thermo Fisher Scientific Inc.（US）
• PerkinElmer Inc.（US）
• Eurofins Scientific SE（Luxembourg）
• Nanion Technologies GmbH（Germany）
• SB Drug Discovery（UK）
• B'SYS GmbH（Switzerland）
• RedShift BioAnalytics, Inc.（US）
• Icagen, Inc.（a division of Eurofins DiscoverX）（US）
• Apredica（a division of Eurofins DiscoverX）（US）
• Inotrem S.A.（France）
• Axxam S.p.A.（Italy）
• Ncardia AG（Germany）

結論と推奨事項

Global HERG Screening Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.79 billion in 2024 to USD 4.37 billion by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032).

The global hERG screening market has seen consistent growth in recent years, driven by the increasing emphasis on drug safety and the demand for more efficient screening methods. The pharmaceutical and biotechnology sectors lead this market, continually seeking reliable technologies to mitigate the risk of drug-induced cardiac arrhythmias. Heightened awareness of drug cardiotoxicity has underscored the critical role of hERG screening in drug development. Advancements in technologies, such as automated patch clamp systems and high-throughput screening, are fueling market expansion. Stricter regulatory demands for drug safety compel pharmaceutical companies to invest in hERG screening solutions, although high initial costs pose challenges for smaller firms. Additionally, accurately predicting a drug's cardiac safety profile remains complex, necessitating ongoing research to enhance predictive models.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Herg Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global HERG Screening Market Segmental Analysis

Global HERG Screening Market is segmented by Type, Ion Channel, Application and region. Based on Type, the market is segmented into Gene KCNH2 and Mutant KCNH2. Based on Ion Channel, the market is segmented into Voltage-Gated and Ligand-Gated. Based on Application, the market is segmented into Antiarrhythmic, Antiphyshotic, Antibiotics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global HERG Screening Market

One of the primary catalysts driving the Global HERG Screening market is the increased focus on drug safety. This growing concern encourages companies to allocate resources towards the development of sophisticated screening technologies that can identify potential compounds with harmful cardiac effects early in the drug discovery process. By prioritizing the identification of safety risks, organizations aim to ensure the efficacy and reliability of their drug candidates, thereby fostering a safer pharmaceutical environment. As a result, the demand for enhanced HERG screening solutions continues to rise, reflecting the industry's commitment to prioritizing patient safety and regulatory compliance throughout the drug development lifecycle.

Restraints in the Global HERG Screening Market

One of the significant limitations in the global hERG screening market is the substantial financial burden associated with purchasing and maintaining advanced screening equipment, such as automated patch clamp systems. This high initial investment poses a particular challenge for smaller pharmaceutical companies and research institutions, hindering their ability to access and utilize the latest hERG screening technologies. As a result, these financial constraints may restrict their research capabilities and slow down the development of new drugs, ultimately impacting their competitiveness in the market. This situation creates a barrier for innovation and technological advancement within the industry.

Market Trends of the Global HERG Screening Market

The Global hERG Screening market is witnessing a notable trend towards heightened consumer awareness and the growing preference for clean label products, prompting pharmaceutical and biotechnology companies to enhance their compound screening processes. The adoption of Automated Patch Clamp Systems is gaining momentum due to their superior throughput capabilities and precise measurements, essential for identifying hERG liabilities efficiently. Additionally, the emphasis on High-Throughput Screening (HTS) technology is reshaping the landscape, enabling researchers to assess multiple compounds simultaneously, thereby accelerating the screening process. This convergence of innovation and demand for safety is driving market growth and reshaping industry practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global HERG Screening Market Size by Type & CAGR (2025-2032)

• Market Overview
• Gene KCNH2
• Mutant KCNH2

Global HERG Screening Market Size by Ion Channel & CAGR (2025-2032)

• Market Overview
• Voltage-Gated
• Ligand-Gated

Global HERG Screening Market Size by Application & CAGR (2025-2032)

• Market Overview
• Antiarrhythmic
• Antiphyshotic
• Antibiotics
• Others

Global HERG Screening Market Size & CAGR (2025-2032)

• North America (Type, Ion Channel, Application)
  • US
  • Canada
• Europe (Type, Ion Channel, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Ion Channel, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Ion Channel, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Ion Channel, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Cytocentrics AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanion Technologies GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB Drug Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B'SYS GmbH (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RedShift BioAnalytics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Icagen, Inc. (a division of Eurofins DiscoverX) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apredica (a division of Eurofins DiscoverX) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotrem S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axxam S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ncardia AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations